Pan, H., Su, Y., Xie, Y., Wang, W., Qiu, W., Chen, W., . . . Shang, A. Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects. Taylor & Francis Group.
Chicago Style (17th ed.) CitationPan, Hongchao, et al. Everestmab, a Novel Long-acting GLP-1/anti GLP-1R Nanobody Fusion Protein, Exerts Potent Anti-diabetic Effects. Taylor & Francis Group.
MLA (9th ed.) CitationPan, Hongchao, et al. Everestmab, a Novel Long-acting GLP-1/anti GLP-1R Nanobody Fusion Protein, Exerts Potent Anti-diabetic Effects. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.